New research from a team of researchers in Taiwan indicates that a peptide fragment derived from cow's milk, known as lactoferricin B25 (LFcinB25), exhibited potent anticancer capability against human stomach cancer cell cultures. The findings, published in the Journal of Dairy Science, provide support for future use of LFcinB25 as a potential therapeutic agent for gastric cancer.
Fuente : http://www.eurekalert.org/pub_releases/2013-11/ehs...
Fuente : http://www.eurekalert.org/pub_releases/2013-11/ehs...